HCW Biologics Inc. Common Stock

HCWBNASDAQUSD
2.54 USD
0.23 (9.96%)🟢LIVE (AS OF 12:32 PM EDT)
🟢Market: OPEN

HCW Biologics Inc. Common Stock (HCWB) trades at $2.54 per share. The technical outlook is "Sell" and the fundamental picture shows "Neutral". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, HCWB appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Aug 24, 2026.

Open?$2.31
High?$2.84
Low?$2.19
Prev. Close?$2.31
Volume?248.3K
Avg. Volume?120.3K
VWAP?$2.51
Rel. Volume?2.06x
Bid / Ask
Bid?$2.46 × 200
Ask?$2.88 × 100
Spread?$0.42
Midpoint?$2.67
Valuation & Ratios
Market Cap?4.2M
Shares Out?1.8M
Float?6.1M
Float %?90.7%
P/E Ratio?N/A
P/B Ratio?0.57
EPS?-$11.66
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.
Employees
35
Market Cap
4.0M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2021-07-20
Address
2929 N COMMERCE PKWY
MIRAMAR, FL 33025
Phone: 954-842-2024
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-2/3)
Medium-Term (Wave)? Neutral(0/3)
Short-Term (Ripple)? Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
0
Momentum?
90
Short Sent.?
80
Piotroski F-Score?2/9Weak
Altman Z-Score?-7.12Distress
Confidence?46%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.34%Low
Short Interest?21.0K
Days to Cover?1.0
Free Float6.1M
Avg Daily Volume71.1K
Settlement Date2026-07-31
Financial Health
Current Ratio?0.06Weak
Quick Ratio?0.06Weak
Cash Ratio?0.04Low
Debt/Equity?0.88Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A
P/B?
Peers
100
S&P
97
0.57CHEAP
P/S?
Peers
100
S&P
93
0.63CHEAP
P/FCF?
N/A
EV/EBITDA?
S&P
97
-1.4CHEAP
EV/Sales?
Peers
100
S&P
84
1.50CHEAP
Returns & Efficiency
ROE?
S&P
3
-288.3%WEAK
ROA?
S&P
3
-80.0%WEAK
Cash Flow & Enterprise
FCF?$-12136822
Enterprise Value?$10.1M
Fundamentals ratios updated end of day